Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL1B | P01584 | 6/20 | 0.43 |
| ▸ | NLRP3 | Q96P20 | 12/20 | 0.41 |
| ▸ | GFER | P55789 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | TNF | P01375 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31057334 | 0.95 | IL1B (0.43) | IL1BNLRP3GFERPOLBKCNH2 | |
| SCHEMBL31057370 | 0.94 | IL1B (0.44) | IL1BNLRP3GFERPOLBKCNH2 | |
| SCHEMBL25304051 | 0.85 | IL1B (0.48) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL29030489 | 0.85 | IL1B (0.48) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL31057127 | 0.84 | IL1B (0.49) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL31057317 | 0.84 | IL1B (0.49) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL31057218 | 0.84 | IL1B (0.49) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL31057341 | 0.82 | IL1B (0.49) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL31057093 | 0.81 | IL1B (0.42) | IL1BNLRP3KCNH2 | |
| SCHEMBL30517841 | 0.81 | NLRP3 (0.45) | IL1BNLRP3KCNH2TNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4646197-A2 | ORGANIC COMPOUNDS AS NLRP3 INHIBITORS | Kodiak Sciences Inc. (US) | 2025-11-12 | — | — | EP | disclosed |
| WO-2024148029-A2 | ORGANIC COMPOUNDS AS NLRP3 INHIBITORS | KODIAK SCIENCES INC. (US) | 2024-07-11 | — | — | WO | disclosed |